The largest retrospective study on antibiotic resistance (AMR) in Africa highlights the need for major investments to enhance laboratory…
The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.
We support low- and middle-income countries to generate, share and use data to improve antimicrobial usage and encourage investment in antimicrobial resistance (AMR).

The threat of mortality, morbidity, and economic loss associated with antimicrobial resistance (AMR) poses a significant burden on…

Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at …

A free online programme developed by the Fleming Fund and The Open University to strengthen the global response to antimicrobial resistance…
- 26
- Active Country Grants
- 20
- Active Regional Grants
- 321
- Supported surveillance sites
- 25
- Countries we work in (up to)
- 170
- National Action Plans developed with Fleming Fund support
- 155
- Countries have supplied data on use of antimicrobial medicines in animals to WOAH database
Studies & Reports
From Studies & Reports, WHO releases Global AMU data to guide progress against AMR , Date: 02/05/2025
A major driver of AMR is the inappropriate use of antimicrobials. This is a common issue in many resource-limited countries with poor…

Stories
From Stories, Transforming AMR surveillance in Nepal through data automation , Date: 30/04/2025
Antimicrobial resistance (AMR) data is vital for informing local interventions, enabling hospitals to improve infection control and…

Programme Update
From Programme Update, Genomics making an impact on AMR in West Africa , Date: 24/03/2025
We spoke to Dr Beverly Egyir about her role as head of the SeqAfrica hub in Ghana, based at the Noguchi Memorial Institute for Medical…

Programme Update
From Programme Update, GEAR up: AMR through a gender and equity lens , Date: 27/02/2025
A new Regional Grant for phase 2 of the Fleming Fund, GEAR up (Gender and Equity within Antimicrobial Resistance) is led by the Liverpool…